These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 5389794

  • 1. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES, Page JG.
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [Abstract] [Full Text] [Related]

  • 2. Genetic control of dicumarol levels in man.
    Vesell ES, Page JG.
    J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
    [Abstract] [Full Text] [Related]

  • 3. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA, Shand DG, Wilkinson GR, Nies AS.
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [Abstract] [Full Text] [Related]

  • 4. Genetic control of drug levels in man: antipyrine.
    Vesell ES, Page JG.
    Science; 1968 Jul 05; 161(3836):72-3. PubMed ID: 5690279
    [Abstract] [Full Text] [Related]

  • 5. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
    Sonne J, Døssing M, Poulsen HE, Pilsgaard H, Rasmussen B, Loft S.
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr 05; 25(4):194-6. PubMed ID: 3583468
    [Abstract] [Full Text] [Related]

  • 6. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
    Uppal R, Garg SK, Sharma PR, Nair CR, Chaudhury RR.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun 05; 18(6):269-71. PubMed ID: 7450928
    [Abstract] [Full Text] [Related]

  • 7. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A, Kauppila AJ, Tuimala RJ, Sotaniemi EA.
    Biomedicine; 1979 Sep 05; 31(5):135-8. PubMed ID: 508896
    [Abstract] [Full Text] [Related]

  • 8. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
    Chiba K, Ishizaki T, Tabuchi T, Wagatsuma T, Nakazawa Y.
    Obstet Gynecol; 1982 Nov 05; 60(5):620-6. PubMed ID: 6815599
    [Abstract] [Full Text] [Related]

  • 9. Genetic and environmental factors affecting drug response in man.
    Vesell ES.
    Fed Proc; 1972 Nov 05; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract] [Full Text] [Related]

  • 10. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW, Van Graft M, Vermeulen NP, Breimer DD.
    Xenobiotica; 1983 Aug 05; 13(8):497-502. PubMed ID: 6649682
    [Abstract] [Full Text] [Related]

  • 11. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T, Nakamura T, Uchino H.
    J Natl Cancer Inst; 1980 Nov 05; 65(5):897-900. PubMed ID: 6933259
    [Abstract] [Full Text] [Related]

  • 12. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
    Albanus L, Jönsson M, Sparf B.
    Acta Pharmacol Toxicol (Copenh); 1977 Jan 05; 40 Suppl 1(1):63-9. PubMed ID: 300543
    [Abstract] [Full Text] [Related]

  • 13. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF, Skinner MH, Blaschke TF.
    Methods Find Exp Clin Pharmacol; 1990 Nov 05; 12(9):631-6. PubMed ID: 2084458
    [Abstract] [Full Text] [Related]

  • 14. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R, Matthias M, Sohr R, Brockmann B, Hüller H.
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr 05; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL, Chang T, Jaffe JM.
    Arch Int Pharmacodyn Ther; 1986 Feb 05; 279(2):181-94. PubMed ID: 3963935
    [Abstract] [Full Text] [Related]

  • 17. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM, Teunissen MW, Breimer DD.
    Drug Metab Dispos; 1981 Feb 05; 9(6):541-4. PubMed ID: 6120813
    [Abstract] [Full Text] [Related]

  • 18. Metabolic disposition of antipyrine in patients with lung cancer.
    Tschanz C, Hignite CE, Huffman DH, Azarnoff DL.
    Cancer Res; 1977 Nov 05; 37(11):3881-6. PubMed ID: 908027
    [Abstract] [Full Text] [Related]

  • 19. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G, Luyten-Kellermann M, Horning M, Stafford M.
    Drug Metab Dispos; 1975 Nov 05; 3(1):47-50. PubMed ID: 234834
    [Abstract] [Full Text] [Related]

  • 20. The effect of midazolam administration on the pharmacokinetics of antipyrine in the rat.
    White SM, Allen JG, Altman JF.
    Xenobiotica; 1987 Jul 05; 17(7):869-73. PubMed ID: 3660856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.